Cryogatt Systems Limited, world leaders in Cryogenic Radio Frequency

Identification (RFID), are proud to announce that CARE Fertility, the

leading IVF brand in the UK and major international key IVF opinion leaders,

have made an equity investment in Cryogatt. This investment is to solidify

the collaboration between Cryogatt and CARE conducted over the past few

years, regarding the introduction of RFID labelling technology into the IVF

process.

 

Collaboration to date has focused on RFID technology product development of

sample labelling – with its associated track, trace and electronic assurity

of correct sample identification – on the cold chain, including site to site

shipping. The application of the technology is likely to expand during this

next phase of collaboration.

 

CARE will be taking up a non-executive Board position with Cryogatt.